Kura Oncology Quote - KURA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

20.62

Bid

20.61

Ask

20.63

Volume

222,846

20.01 Day's Range 20.68

7.41 52 Week Range 24.17

Market Cap

1.565B

Previous Close

20.49

Open

20.39

Last Trade

20.62

Last Trade Time

14:02:51

Financial Volume

US$ 4,523,454

VWAP

20.2986

Average Volume (3m)

725,854

Shares Outstanding

76,180,620

Dividend Yield

PE Ratio

-10.25

Earnings Per Share (EPS)

-2

Revenue

Net Profit

-152.63M

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Website

www.kuraoncology.com

Headquarters

Wilmington, Delaware, USA

Founded

2015

Kura Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KURA. The last closing price for Kura Oncology was US$20.49. Over the last year, Kura Oncology shares have traded in a share price range of US$ 7.41 to US$ 24.17.

Kura Oncology currently has 76,180,620 shares outstanding. The market capitalization of Kura Oncology is US$1.56 billion. Kura Oncology has a price to earnings ratio (PE ratio) of -10.25.

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.99	5.04330106979	19.63	21.85	19.41	1117469	20.84421388	CS
4	-0.59	-2.7817067421	21.21	22.675	19.41	735354	20.9919887	CS
12	0.25	1.22729504173	20.37	23.1	16.79	725854	20.30622574	CS
26	6.63	47.3909935668	13.99	24.17	13.29	1086070	19.82708382	CS
52	9.71	89.0009165903	10.91	24.17	7.41	950736	15.59956203	CS
156	-1.58	-7.11711711712	22.2	24.17	7.41	832962	14.97863883	CS
260	1.01	5.15043345232	19.61	42.82	6.34	718409	17.73955107	CS

Symbol	Price	Vol.
DNDelta 9 Cannabis Inc	$ 0.015 (50.00%)	411.77k
SCYScandium International Mining Corp	$ 0.02 (33.33%)	11k
BNGBengal Energy Ltd	$ 0.035 (16.67%)	33k
GVCGlacier Media Inc	$ 0.11 (15.79%)	2.82k
FANSFansUnite Entertainment Inc	$ 0.04 (14.29%)	326.14k
NCFNorthcliff Resources Ltd	$ 0.02 (-20.00%)	39k
AMMAlmaden Minerals Ltd New	$ 0.085 (-19.05%)	3.24k
XLYAuxly Cannabis Group Inc	$ 0.025 (-16.67%)	428.03k
IVQInvesque Inc	$ 0.145 (-14.71%)	101.2k
ASNDAscendant Resources Inc	$ 0.035 (-12.50%)	11k
TTelus Corp	$ 20.84 (-1.70%)	5.32M
FCUFission Uranium Corp	$ 1.18 (-0.84%)	5.12M
VGCXVictoria Gold Corp	$ 1.30 (-4.41%)	4.34M
BITFBitfarms Ltd	$ 3.63 (-4.47%)	2.4M
ACAir Canada	$ 17.45 (4.80%)	2.34M

Symbol

Price

Vol.